{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T07:56:12Z","timestamp":1671263772603},"reference-count":53,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Severe injury and infection are often followed by accelerated protein catabolism and acute insulin resistance. This results in several effects that complicate and prolong recovery, including weakness, immobility, impaired wound healing, and organ dysfunction. Recent studies have demonstrated the development of GH resistance during severe inflammation, providing a potential mechanism for the protein loss that follows injury and infection. To understand this GH resistance, we recently developed a murine model of acute injury. Mice were subjected to soft-tissue injury, alone or combined with hemorrhage, and injected iv with GH 30, 60, or 90 minutes later. Hepatic GH signaling was measured via Western analysis. GH-induced signal transducer and activator of transcription 5 phosphorylation was decreased immediately after completion of the trauma procedure, and at 30 and 60 minutes, but further decreased by 90 minutes after trauma. Combined trauma and hemorrhage resulted in severely decreased GH-induced signal transducer and activator of transcription 5 phosphorylation compared with trauma alone, and this was true at all time points studied. Western analysis revealed an apparent decrease in the molecular weight of the hepatic GH receptor (GHR) after trauma and hemorrhage, but not trauma alone. Additional studies determined that the hemorrhage-induced decrease in receptor size was not due to changes in GHR N-linked glycosylation. These results suggest that GH sensitivity is rapidly impaired after acute injury and that trauma combined with hemorrhage results in a more severe form of GH resistance resulting from alteration or inactivation of hepatic GHR.<\/jats:p>","DOI":"10.1210\/en.2012-2134","type":"journal-article","created":{"date-parts":[[2013,2,16]],"date-time":"2013-02-16T02:24:12Z","timestamp":1360981452000},"page":"1577-1588","source":"Crossref","is-referenced-by-count":2,"title":["Hepatic Growth Hormone Resistance After Acute Injury"],"prefix":"10.1210","volume":"154","author":[{"given":"Ryan M.","family":"Corrick","sequence":"first","affiliation":[{"name":"Department of Pathology (R.M.C., L.L., J.L.M.), Division of Molecular and Cellular Pathology,, Birmingham, Alabama 35294"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"first","affiliation":[{"name":"Department of Pathology (R.M.C., L.L., J.L.M.), Division of Molecular and Cellular Pathology,, Birmingham, Alabama 35294"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart J.","family":"Frank","sequence":"first","affiliation":[{"name":"Department of Medicine (S.J.F.), University of Alabama at Birmingham, Birmingham, Alabama 35294"},{"name":"Veterans Affairs Medical Center (J.L.M., S.J.F.), Birmingham, Alabama 35233"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph L.","family":"Messina","sequence":"first","affiliation":[{"name":"Department of Pathology (R.M.C., L.L., J.L.M.), Division of Molecular and Cellular Pathology,, Birmingham, Alabama 35294"},{"name":"Veterans Affairs Medical Center (J.L.M., S.J.F.), Birmingham, Alabama 35233"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071612522120600_B1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00000658-198007000-00014","article-title":"Muscle and plasma amino acids following injury. Influence of intercurrent infection","volume":"192","author":"Askanazi","year":"1980","journal-title":"Ann Surg"},{"key":"2020071612522120600_B2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00003246-199604000-00005","article-title":"A descriptive study of skeletal muscle metabolism in critically ill patients: free amino acids, energy-rich phosphates, protein, nucleic acids, fat, water, and electrolytes","volume":"24","author":"Gamrin","year":"1996","journal-title":"Crit Care Med"},{"key":"2020071612522120600_B3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.nutr.26.061505.111307","article-title":"Risks and benefits of nutritional support during critical illness","volume":"26","author":"Debaveye","year":"2006","journal-title":"Annu Rev Nutr"},{"key":"2020071612522120600_B4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2174\/1389200043335405","article-title":"Effect of growth factors as therapeutic drugs on hepatic metabolism during the systemic inflammatory response syndrome","volume":"5","author":"Jeschke","year":"2004","journal-title":"Curr Drug Metab"},{"key":"2020071612522120600_B5","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/j.biocel.2005.05.009","article-title":"Post burn muscle wasting and the effects of treatments","volume":"37","author":"Pereira","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"key":"2020071612522120600_B6","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/qjmed\/89.11.813","article-title":"Growth hormone therapy for protein catabolism","volume":"89","author":"Jenkins","year":"1996","journal-title":"QJM"},{"key":"2020071612522120600_B7","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1177\/0148607197021006324","article-title":"Accelerated nitrogen loss after traumatic injury is not attenuated by achievement of energy balance","volume":"21","author":"Frankenfield","year":"1997","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"2020071612522120600_B8","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1093\/ajcn\/53.5.1242","article-title":"Mild orotic aciduria and uricosuria in severe trauma victims","volume":"53","author":"Jeevanandam","year":"1991","journal-title":"Am J Clin Nutr"},{"key":"2020071612522120600_B9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/011542650602100168","article-title":"The origins of cachexia in acute and chronic inflammatory diseases","volume":"21","author":"Delano","year":"2006","journal-title":"Nutr Clin Pract"},{"key":"2020071612522120600_B10","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/MCC.0b013e328306a965","article-title":"Is there a role for growth hormone therapy in refractory critical illness?","volume":"14","author":"Taylor","year":"2008","journal-title":"Curr Opin Crit Care"},{"key":"2020071612522120600_B11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1017\/S0265021507003262","article-title":"Critical illness myopathy: sepsis-mediated failure of the peripheral nervous system","volume":"42","author":"Friedrich","year":"2008","journal-title":"Eur J Anaesthesiol Suppl"},{"key":"2020071612522120600_B12","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.beem.2011.06.002","article-title":"The GH\/IGF-1 system in critical illness","volume":"25","author":"Elijah","year":"2011","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2020071612522120600_B13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00075197-200203000-00013","article-title":"Dangers of growth hormone therapy in critically ill patients","volume":"5","author":"Ruokonen","year":"2002","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"2020071612522120600_B14","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/00005373-198703000-00006","article-title":"Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients","volume":"27","author":"Streat","year":"1987","journal-title":"J Trauma"},{"key":"2020071612522120600_B15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2265.1991.tb03495.x","article-title":"Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I","volume":"35","author":"Ross","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612522120600_B16","first-page":"590","article-title":"The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion","volume":"82","author":"Van den Berghe","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612522120600_B17","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1097\/00003246-199609000-00006","article-title":"Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin-like growth factor binding proteins, and induction of an insulin-like growth factor binding protein 3 protease","volume":"24","author":"Timmins","year":"1996","journal-title":"Crit Care Med"},{"key":"2020071612522120600_B18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev.ph.47.030185.002411","article-title":"Mode of action of pituitary growth hormone on target cells","volume":"47","author":"Isaksson","year":"1985","journal-title":"Annu Rev Physiol"},{"key":"2020071612522120600_B19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0092-8674(93)90415-M","article-title":"Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase","volume":"74","author":"Argetsinger","year":"1993","journal-title":"Cell"},{"key":"2020071612522120600_B20","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1210\/endo.135.5.7956946","article-title":"Interaction of the growth hormone receptor cytoplasmic domain with the JAK2 tyrosine kinase","volume":"135","author":"Frank","year":"1994","journal-title":"Endocrinology"},{"key":"2020071612522120600_B21","first-page":"519","article-title":"The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in theactivation of Stats 1, 3, and 5 by GH","volume":"10","author":"Smit","year":"1996","journal-title":"Mol Endocrinol"},{"key":"2020071612522120600_B22","first-page":"998","article-title":"Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor","volume":"10","author":"Sotiropoulos","year":"1996","journal-title":"Mol Endocrinol"},{"key":"2020071612522120600_B23","first-page":"1425","article-title":"Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase","volume":"10","author":"Yi","year":"1996","journal-title":"Mol Endocrinol"},{"key":"2020071612522120600_B24","doi-asserted-by":"crossref","first-page":"13262","DOI":"10.1074\/jbc.270.22.13262","article-title":"Intermittent plasma growth hormone triggers tyrosine phosphorylation and nuclear translocation of a liver-expressed, Stat 5-related DNA binding protein. Proposed role as an intracellular regulator of male-specific liver gene transcription","volume":"270","author":"Waxman","year":"1995","journal-title":"J Biol Chem"},{"key":"2020071612522120600_B25","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.1074\/jbc.271.10.5929","article-title":"Growth hormone activation of Stat 1, Stat 3, and Stat 5 in rat liver: differential kinetics of hormone desensitization and growth hormone stimulation of both tyrosine phosphorylation and serine\/threonine phosphorylation","volume":"271","author":"Ram","year":"1996","journal-title":"J Biol Chem"},{"key":"2020071612522120600_B26","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1210\/endo.142.9.8400","article-title":"STAT5b is required for GH-induced liver IGF-I gene expression","volume":"142","author":"Davey","year":"2001","journal-title":"Endocrinology"},{"key":"2020071612522120600_B27","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1210\/er.2009-0010","article-title":"The role of liver-derived insulin-like growth factor-I","volume":"30","author":"Ohlsson","year":"2009","journal-title":"Endocr Rev"},{"key":"2020071612522120600_B28","doi-asserted-by":"crossref","first-page":"E472","DOI":"10.1152\/ajpendo.00107.2002","article-title":"Tumor necrosis factor mediates hepatic growth hormone resistance during sepsis","volume":"283","author":"Yumet","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071612522120600_B29","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1097\/01.CCM.0000215113.66070.E0","article-title":"Hepatic growth hormone resistance during sepsis is associated with increased suppressors of cytokine signaling expression and impaired growth hormone signaling","volume":"34","author":"Yumet","year":"2006","journal-title":"Crit Care Med"},{"key":"2020071612522120600_B30","doi-asserted-by":"crossref","first-page":"E1856","DOI":"10.1152\/ajpendo.00581.2006","article-title":"Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2\/STAT5 signal transduction and STAT5b DNA binding","volume":"292","author":"Chen","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071612522120600_B31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1677\/joe.0.1510287","article-title":"Reduction in circulating IGF-I and hepatic IGF-I mRNA levels after caecal ligation and puncture are associated with differential regulation of hepatic IGF-binding protein-1, -2 and -3 mRNA levels","volume":"151","author":"Rodriguez-Arnao","year":"1996","journal-title":"J Endocrinol"},{"key":"2020071612522120600_B32","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/me.2010-0224","article-title":"Role of of reactive oxygen species in injury-induced insulin resistance","volume":"25","author":"Zhai","year":"2011","journal-title":"Mol Endocrinol"},{"key":"2020071612522120600_B33","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1210\/endo.137.7.8770909","article-title":"Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo","volume":"137","author":"Chow","year":"1996","journal-title":"Endocrinology"},{"key":"2020071612522120600_B34","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1210\/endo.143.3.8692","article-title":"Impairment of liver GH receptor signaling by fasting","volume":"143","author":"Beauloye","year":"2002","journal-title":"Endocrinology"},{"key":"2020071612522120600_B35","doi-asserted-by":"crossref","first-page":"E63","DOI":"10.1152\/ajpendo.00555.2002","article-title":"Sepsis-induced muscle growth hormone resistance occurs independently of STAT5 phosphorylation","volume":"285","author":"Hong-Brown","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071612522120600_B36","doi-asserted-by":"crossref","first-page":"G107","DOI":"10.1152\/ajpgi.00217.2002","article-title":"Hemorrhage induces the rapid development of hepatic insulin resistance","volume":"284","author":"Ma","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2020071612522120600_B37","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1210\/en.2004-0524","article-title":"Mechanisms of hemorrhage-induced hepatic insulin resistance: role of tumor necrosis factor-\u03b1","volume":"145","author":"Ma","year":"2004","journal-title":"Endocrinology"},{"key":"2020071612522120600_B38","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1074\/jbc.273.4.2344","article-title":"Involvement of the Src homology 2-containing tyrosine phosphatase SHP-2 in growth hormone signaling","volume":"273","author":"Kim","year":"1998","journal-title":"J Biol Chem"},{"key":"2020071612522120600_B39","doi-asserted-by":"crossref","first-page":"24565","DOI":"10.1074\/jbc.M101281200","article-title":"Growth hormone (GH)-induced dimerization inhibits phorbol ester-stimulated GH receptor proteolysis","volume":"276","author":"Zhang","year":"2001","journal-title":"J Biol Chem"},{"key":"2020071612522120600_B40","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1210\/me.2007-0561","article-title":"Endotoxin-induced proteolytic reduction in hepatic growth hormone (GH) receptor: a novel mechanism for GH insensitivity","volume":"22","author":"Wang","year":"2008","journal-title":"Mol Endocrinol"},{"key":"2020071612522120600_B41","doi-asserted-by":"crossref","first-page":"G646","DOI":"10.1152\/ajpgi.00178.2002","article-title":"Interleukin 6 inhibits hepatic growth hormone signaling via up regulation of Cis and Socs-3","volume":"284","author":"Denson","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2020071612522120600_B42","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1172\/JCI11895","article-title":"Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia","volume":"108","author":"Schaefer","year":"2001","journal-title":"J Clin Invest"},{"key":"2020071612522120600_B43","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0303-7207(94)90200-3","article-title":"In vitro mutagenesis of growth hormone receptor Asn-linked glycosylation sites","volume":"106","author":"Harding","year":"1994","journal-title":"Mol Cell Endocrinol"},{"key":"2020071612522120600_B44","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1210\/endo-117-2-650","article-title":"Measurement of growth hormone and prolactin receptor turnover in rat liver","volume":"117","author":"Baxter","year":"1985","journal-title":"Endocrinology"},{"key":"2020071612522120600_B45","doi-asserted-by":"crossref","first-page":"13434","DOI":"10.1074\/jbc.274.19.13434","article-title":"Insulin inhibits growth hormone signaling via the growth hormone receptor\/JAK2\/STAT5B pathway","volume":"274","author":"Ji","year":"1999","journal-title":"J Biol Chem"},{"key":"2020071612522120600_B46","doi-asserted-by":"crossref","first-page":"17694","DOI":"10.1074\/jbc.272.28.17694","article-title":"Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase","volume":"272","author":"Ram","year":"1997","journal-title":"J Biol Chem"},{"key":"2020071612522120600_B47","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.bbrc.2007.08.087","article-title":"S731 in the transactivation domain modulates STAT5b activity","volume":"362","author":"Weaver","year":"2007","journal-title":"Biochem Biophys Res Comm"},{"key":"2020071612522120600_B48","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1210\/mend.15.12.0746","article-title":"Serine phosphorylation of GH-activated signal transducer and activator of transcription 5a (STAT5a) and STAT5b: impact on STAT5 transcriptional activity","volume":"15","author":"Park","year":"2001","journal-title":"Mol Endocrinol"},{"key":"2020071612522120600_B49","first-page":"E565","article-title":"GH insensitivity induced by endotoxin injection is associated with decreased liver GH receptors","volume":"276","author":"Defalque","year":"1999","journal-title":"Am J Physiol"},{"key":"2020071612522120600_B50","doi-asserted-by":"crossref","first-page":"13215","DOI":"10.1073\/pnas.94.24.13215","article-title":"A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor\/binding protein gene (the Laron mouse)","volume":"94","author":"Zhou","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020071612522120600_B51","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12020-007-9021-2","article-title":"Insulin regulation of growth hormone receptor gene expression: involvement of both the PI-3 kinase and MEK\/ERK signaling pathways","volume":"32","author":"Bennett","year":"2007","journal-title":"Endocrine"},{"key":"2020071612522120600_B52","doi-asserted-by":"crossref","first-page":"21709","DOI":"10.1016\/S0021-9258(17)31863-X","article-title":"Domains of the growth hormone receptor required for association and activation of JAK2 tyrosine kinase","volume":"269","author":"VanderKuur","year":"1994","journal-title":"J Biol Chem"},{"key":"2020071612522120600_B53","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1210\/en.2011-1452","article-title":"Growth hormone-induced JAK2 signaling and GH receptor down-regulation: role of GH receptor intracellular domain tyrosine residues","volume":"153","author":"Deng","year":"2012","journal-title":"Endocrinology"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/154\/4\/1577\/10387415\/endo1577.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/154\/4\/1577\/10387415\/endo1577.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T20:59:29Z","timestamp":1644353969000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/154\/4\/1577\/2423569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,1]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2012-2134","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,1]]}}}